BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38785499)

  • 1. Pharmacy Workload in Clinical Trial Management: A Preliminary Complexity Assessment Tool for Sponsored Oncology and Haematology Trials.
    Gasperoni L; Masini C; Toscano G; Cafaro A; Zani C; Andrianò C; Silimbani P; Donati C; Bortolin G; Cecco S
    Curr Oncol; 2024 May; 31(5):2867-2873. PubMed ID: 38785499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of complexity categories for an investigational drug services complexity scoring tool to assess pharmacy effort in clinical trial initiation and maintenance.
    Song K; Yu M; McLuckie R; O'Brien K; Harrison M; Nguyen V; Kraft M; Abdelghany O; Phillips MS; Roberts J; Johnston S; Young CA; Redic KA
    Am J Health Syst Pharm; 2023 Oct; 80(21):1557-1563. PubMed ID: 37335865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing and piloting a communication assessment tool assessing patient perspectives on communication with pharmacists (CAT-Pharm).
    Scala D; Mucherino S; Wirth F; Orlando V; Polidori P; Faggiano ME; Iovine D; Saturnino P; Cattel F; Costantini A; Giua C; Makoul G; Azzopardi LM; Menditto E
    Int J Clin Pharm; 2022 Aug; 44(4):1037-1045. PubMed ID: 35211832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a tool to allocate inpatient specialized pharmacy resources at a comprehensive cancer center.
    Smith AT; Kennerly-Shah JM; Kusoski CL
    J Oncol Pharm Pract; 2020 Oct; 26(7):1686-1694. PubMed ID: 32865162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey about the contents and features of oncology clinical pharmacy services and self-evaluations of the oncology pharmacists in China.
    Wang Y; Dai Y; Yang J; Zhou H; Chen Z; Li G
    J Clin Pharm Ther; 2020 Oct; 45(5):1106-1113. PubMed ID: 32592203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How many research nurses for how many clinical trials in an oncology setting? Definition of the Nursing Time Required by Clinical Trial-Assessment Tool (NTRCT-AT).
    Milani A; Mazzocco K; Stucchi S; Magon G; Pravettoni G; Passoni C; Ciccarelli C; Tonali A; Profeta T; Saiani L
    Int J Nurs Pract; 2017 Feb; 23(1):. PubMed ID: 27925377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring clinical trial-associated workload in a community clinical oncology program.
    Good MJ; Lubejko B; Humphries K; Medders A
    J Oncol Pract; 2013 Jul; 9(4):211-5. PubMed ID: 23942924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Many Cancer Clinical Trials Can a Clinical Research Coordinator Manage? The Clinical Research Coordinator Workload Assessment Tool.
    Fabbri F; Gentili G; Serra P; Vertogen B; Andreis D; Dall'Agata M; Fabbri G; Gallà V; Massa I; Montanari E; Monti M; Pagan F; Piancastelli A; Ragazzini A; Rudnas B; Testoni S; Valmorri L; Zingaretti C; Zumaglini F; Nanni O
    JCO Oncol Pract; 2021 Jan; 17(1):e68-e76. PubMed ID: 32936710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacy workload in medical and surgical patients: effect of patient partition, disease complexity and major disease category.
    Stuchbery P; Kong DC; DeSantis GN; Lo SK
    Int J Pharm Pract; 2010 Jun; 18(3):159-66. PubMed ID: 20509349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of clinical pharmacy in oncology and hematology centers: A systematic review.
    Oliveira CS; Silva MP; Miranda ÍKSPB; Calumby RT; de Araújo-Calumby RF
    J Oncol Pharm Pract; 2021 Apr; 27(3):679-692. PubMed ID: 33302824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of clinical pharmacists in outpatient oncology practices: A review.
    Gatwood J; Gatwood K; Gabre E; Alexander M
    Am J Health Syst Pharm; 2017 Oct; 74(19):1549-1557. PubMed ID: 28947527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an operational productivity tool within a cancer treatment center pharmacy.
    Achey TS; Riffle AR; Rose RM; Earl M
    Am J Health Syst Pharm; 2018 Nov; 75(21):1736-1741. PubMed ID: 30282665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' roles in oncology pharmacy services: Results of a global survey.
    Holle LM; Harris CS; Chan A; Fahrenbruch RJ; Labdi BA; Mohs JE; Norris LB; Perkins J; Vela CM
    J Oncol Pharm Pract; 2017 Apr; 23(3):185-194. PubMed ID: 26854267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of clinical pharmacy services in a hematology/oncology ward in Morocco.
    Moukafih B; Abahssain H; Mrabti H; Errihani H; Rahali Y; Taoufik J; Chaibi A
    J Oncol Pharm Pract; 2021 Mar; 27(2):305-311. PubMed ID: 32326873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practising prioritisation: exploring variation in applying a clinical pharmacy risk stratification tool.
    McIntyre FB; Vickers L; Wallem A; van de l'Isle M; McLean A; Souter C
    Eur J Hosp Pharm; 2024 Apr; 31(3):267-273. PubMed ID: 36600455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative dual-site analysis of the pharmacist discharge care (PHARM-DC) intervention using the CFIR framework.
    Murry LT; Keller MS; Pevnick JM; Schnipper JL; Kennelty KA;
    BMC Health Serv Res; 2022 Feb; 22(1):186. PubMed ID: 35151310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Clinical Pharmacy Services for Phase 1 Clinical Trials.
    Saunders J; Murli S; Rudek MA; Khandoobhai A; DeLisa A; Goodrich A; Mighty J
    J Hematol Oncol Pharm; 2022 Jun; 12(3):131-137. PubMed ID: 36698509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Training workload in the investigational drug service of a university hospital center.
    Martel-Côté N; Choquette R; Côté-Sergerie C; Lebel D; Bussières JF; Tanguay C
    Am J Health Syst Pharm; 2023 Apr; 80(8):495-502. PubMed ID: 36626282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.